Overview

Azithromycin for Critical Asthma - Pediatrics

Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
Phase:
PHASE2
Details
Lead Sponsor:
Johns Hopkins All Children's Hospital
Treatments:
Azithromycin